Tag: $Sarepta

Sarepta Jumps on Broad Approval for Muscular Dystrophy Drug

Sarepta Therapeutics Inc.’s (SRPT) gene therapy received expanded US approval to include more children with a deadly muscle disease, expanding the market for a controversial treatment that still hasn’t proved its benefit in clinical trials.